Krystal Biotech Announces Second Quarter 2025 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St on track for subdued September start as high yields, oil prices dent sentiment
- Oil up more than 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
Krystal Biotech, Inc. (KRYS) Tops Q2 EPS by 7c, Beats on Revenue
August 4, 2025 7:03 AM EDTKrystal Biotech, Inc. (NASDAQ: KRYS) reported Q2 EPS of $1.29, $0.07 better than the analyst estimate of $1.22. Revenue for the quarter came in at $96.04 million versus the consensus estimate of $92.24 million.
For earnings history and earnings-related data on Krystal Biotech, Inc. (KRYS) click here.
... More